Company Filing History:
1 out of 210 
1 out of 43 
1 out of 5,089 
Years Active: 2015
Title: Matthieu Yver: Innovator in Vaccine Production
Introduction
Matthieu Yver is a notable inventor based in Lyons, France. He has made significant contributions to the field of vaccine production, particularly in the development of modified viral strains. His work focuses on improving the efficiency of vaccine seed production for influenza viruses.
Latest Patents
Yver holds a patent for "Modified viral strains and method for improving the production of vaccine seeds of influenza virus." This patent includes the modified influenza A/PR/8/34 virus and reassortant influenza A/PR/8/34 virus, which feature a modified PB1 gene. His methods aim to enhance the production of HA (hemagglutinin) and NA (neuraminidase) vaccine glycoproteins. He has 1 patent to his name.
Career Highlights
Throughout his career, Matthieu Yver has worked with esteemed institutions such as Université Claude Bernard – Lyon 1 and Hospices Civils de Lyon. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Yver has collaborated with notable colleagues, including Vincent Moules and Manuel Rosa-Calatrava. These partnerships have enriched his research and expanded the impact of his innovations.
Conclusion
Matthieu Yver's work in the field of vaccine production exemplifies the importance of innovation in public health. His contributions continue to influence the development of effective vaccines against influenza viruses.